The optimal slow pathway ablation site in atrioventricular nodal reentrant tachycardia cases with an inferiorly

Ryoya Takizawa1, Yosuke Nakatani1, Yutaka Take1

  • 1Division of Cardiology, Gunma Prefectural Cardiovascular Center, Gunma, Japan.

Insights

Optimal slow pathway (SP) ablation for atrioventricular nodal reentrant tachycardia requires careful consideration of His bundle (HIS) location. Ablation should be performed more inferiorly and posteriorly when the HIS is inferiorly located.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Medical Devices

Background:

  • The optimal site for slow pathway (SP) ablation in patients with atrioventricular nodal reentrant tachycardia (AVNRT) and an inferiorly located His bundle (HIS) is not well-defined.
  • Accurate identification of the HIS location is crucial for successful and safe SP ablation procedures.

Purpose of the Study:

  • To investigate the relationship between the His bundle (HIS) location and the successful slow pathway (SP) ablation site in patients with atrioventricular nodal reentrant tachycardia (AVNRT).
  • To provide guidance on optimal SP ablation strategies in cases with an inferiorly positioned HIS.

Main Methods:

  • Utilized electroanatomical mapping in 45 patients undergoing AVNRT ablation.
  • Assessed the spatial relationship between the HIS and successful SP ablation sites using superior-inferior, anterior-posterior, and right-left coordinates.
  • Correlated HIS superior-inferior location (HISSI) with SP ablation site location.

Main Results:

  • The superior-inferior location of the HIS (HISSI) was significantly correlated with the superior-inferior (SPSI) and anterior-posterior (SPAP) locations of the SP ablation site.
  • The distance between the HIS and the SP ablation site was not influenced by the HIS location.
  • No significant difference in atrial/ventricular potential amplitude ratios was observed between high and low HIS groups.

Conclusions:

  • In patients with an inferiorly located His bundle (HIS), slow pathway (SP) ablation should be targeted at a more inferior and posterior location compared to typical cases.
  • These findings aid in refining ablation strategies for AVNRT, particularly in challenging anatomical variations.
Abstract

Related Concept Videos

Conduction System of the Heart01:20

Conduction System of the Heart

The cardiac conduction system produces and transmits electrical impulses that prompt myocardial contraction, ensuring efficient heart function. This intricate system ensures that the heart beats in a coordinated and efficient manner, beginning with the atria and then the ventricles. The conduction system optimizes cardiac output by maintaining this precise sequence, which is crucial for adequate blood circulation.
This system relies on the unique properties of nodal and Purkinje cells:...
1.0K
Disturbances in Heart Rhythm01:28

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
952
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers01:20

Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers

Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
832